Therefore, we further explored the molecular regulatory mechanism of CVB-D on the improvement of DCM by taking the NLRP3-mediated cardiomyocyte pyroptosis as the research route. This evidence concerns the gene NLRP3 and familial dilated cardiomyopathy.